このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Effect of Breastfeedıng and Kangaroo Care Applıed Before Heel Blood Collectıon on Newborn Paın and Comfort

2026年5月5日 更新者:BÜŞRA SERTAKAN BAŞPINAR、Cumhuriyet University

The Effect of Breastfeedıng and Kangaroo Care Applıed Before Heel Blood Collectıon on Newborn Paın and Comfort: A Randomızed Controlled Study

This research will be conducted using a randomized controlled, double-blind experimental design to determine the effects of breastfeeding and kangaroo care on the pain and comfort of newborn babies before heel prick blood sampling. The study group will consist of newborn babies, and one of the observers administering the pain and comfort scores will be independent of the research participants, with the observer evaluating the babies without knowing which group they belong to.

Study Hypotheses H0a = Breastfeeding before heel prick test in newborns does not affect the baby's pain.

H1a = Breastfeeding before heel prick test in newborns reduces the baby's pain. H0b = Kangaroo care before heel prick test in newborns does not affect the baby's pain.

H1b = Kangaroo care before heel prick test in newborns reduces the baby's pain. H0c = Breastfeeding before heel prick test in newborns does not affect the baby's comfort level.

H1c = Breastfeeding before heel prick test in newborns increases the baby's comfort level.

H0d = Kangaroo care before heel prick test in newborns does not affect the baby's comfort level.

H1d = Kangaroo care before heel prick test in newborns increases the baby's comfort level.

The research is planned to be conducted at the Obstetrics and Gynecology Department of Sivas Cumhuriyet University Women's and Children's Hospital in Sivas city center between February 1, 2025 and March 1, 2026.

The study population will consist of newborns born by cesarean section and admitted to the Obstetrics and Gynecology ward of Sivas Cumhuriyet University Health Services Application and Research Hospital. The study sample will comprise newborns born by cesarean section and admitted to the Obstetrics and Gynecology ward of Sivas Cumhuriyet University Health Services Application and Research Hospital who meet the study criteria. The study (breastfeeding group, kangaroo care group) and control groups will consist of a total of 120 newborns.

The following instruments will be used to collect research data: Newborn and Parent Demographic Information Form, Neonatal Infant Pain Scale (NIPS), Neonatal Comfort Behavior Scale, informed consent form, and Blinded Evaluator NIPS form. The study will also utilize a pulse oximeter, a camera, and a stopwatch.

調査の概要

詳細な説明

Heel prick blood sampling is one of the invasive procedures frequently performed in divorces. Ensuring the proper continuation and survival of fractures that occur during this procedure is of great importance. Nurses have responsibilities regarding the identification of cooling and comfort components of equipment, the operation of appropriate interventions using this equipment, and the maintenance of basic comfort enhancement. While there are limited industrial studies on the combined use of breastfeeding and kangaroo care for pain relief, no studies have been found that evaluate pain and temperature together. There is a need for current reports on monitoring, prevention, and treatment related to pain control in preterm and term newborns monitored both in and out of hospitals. In this context, the aim of our study is to determine the duration of pain and temperature associated with breastfeeding and kangaroo care applied before heel prick blood sampling in newborns.

研究の種類

介入

入学 (実際)

120

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Merkez
      • Sivas、Merkez、トルコ(Türkiye)、58030
        • Sivas Cumhuriyet Üniversitesi Sağlık Hizmetleri Uygulama ve Araştırma Hastanesinde Kadın Hastalıkları Obs-tetri servisi

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • Parental consent must be obtained in accordance with the participant information and consent form
  • The baby must be term, between 37-42 weeks gestation
  • Birth weight must be 2500 grams or more
  • The mother must be present with the baby
  • The baby must be healthy (no physical, metabolic, or genetic diseases, no surgical procedures have been performed)
  • There must be no condition that prevents pain assessment (neuromotor developmental delay, etc.)
  • The baby must not have undergone any invasive procedures other than routine interventions
  • The baby must have been born by cesarean section
  • The mother must speak and understand Turkish fluently

Exclusion Criteria:

  • Pre-procedure NIPS score of 3 or higher
  • Lack of parental consent based on participant information and consent form
  • Newborn born before 37 weeks of gestation
  • Birth weight under 2500 grams
  • Unstable general condition
  • Vaginal delivery
  • Invasive procedures performed on the baby other than routine procedures
  • Failure to obtain heel prick blood on the first attempt
  • Mother not speaking Turkish

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:非ランダム化
  • 介入モデル:階乗代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:This is the group where the baby is breastfed before the heel prick blood test. In this group, the e
Breastfeeding Group (Group 1) Each baby in the group will be breastfed for 15-30 minutes before the heel prick blood test. Physiological parameters, NIPS, and comfort behavior will be evaluated before, during and after the procedure. In addition, the duration of the newborn's crying will be recorded with a stopwatch during the heel prick blood test.
Before the heel prick blood test, a newborn information form and a parent identification form will be completed. Parents will be given information about breastfeeding, and physiological parameters, NIPS (Neural Network Indicators), and comfort behavior will be evaluated before the procedure. Each baby in the group will be breastfed for 15-30 minutes before the heel prick blood test. Physiological parameters, NIPS, and comfort behavior will be evaluated during and after the procedure. In addition, the duration of the newborn's crying will be recorded with a stopwatch during the heel prick blood test. The newborn will be recorded with a camera during the procedure for evaluation by the blind evaluator.
実験的:This group receives skin-to-skin contact (kangaroo care) before the heel prick blood test on the bab
Kangaroo Care Group (Group 2) Each baby in the group will be given 30 minutes of kangaroo care before heel prick blood is taken. Physiological parameters, NIPS (Neural Network Imaging System) scores, and comfort behavior will be evaluated before, during, and after the procedure.
Before the procedure, a newborn information form and a parent identification form will be completed. Parents will be given information about kangaroo care, and physiological parameters, NIPS (Neural Network Indicators), and comfort behavior will be evaluated before the procedure. Each baby in the group will be provided with kangaroo care for 30 minutes before the heel prick blood sample is taken. Physiological parameters, NIPS, and comfort behavior will be evaluated during and after the procedure. In addition, the duration of the newborn's crying will be recorded with a stopwatch during the procedure. The newborn will be recorded with a camera during the procedure for evaluation by the blind evaluator.
実験的:This is the group that receives standard care.
Control Group (Group 3) Physiological parameters, NIPS (Neuroprocedure Testing System), and comfort behavior will be evaluated before, during, and after the procedure.
No intervention will be performed. Routine hospital procedure will be applied.Physiological parameters, NIPS (Neuro-Visual Imaging System), and comfort behavior will be evaluated before, during, and after the procedure. Additionally, the newborn's crying duration will be recorded using a stopwatch during the procedure. The newborn will also be recorded on camera during the procedure for evaluation by a blind evaluator.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Determining the appropriate interval for breastfeeding and kangaroo care in newborns before heel prick blood sampling, as well as assessing pain and temperature.
時間枠:about a year
Newborn Infant Pain Scale Assessment Form: The NIPS Form is used to assess pain and consists of six behavioral responses: facial expression, emission pattern, arms, fullness, and volume. Crying performance is given three points (0-1-2), while other behaviors are given only two points (0-1). The total score is calculated based on the Neonatal Pain Scale, with a maximum score of 7 and a minimum score of 0. A NIPS score between 0-2 indicates no pain and requires no intervention. A pain score between 3-4 indicates moderate acoustic pain, and complementary and alternative interventions are applied. A pain score above four suggests complementary and alternative Neonatal Comfort Behavior Scale (NICS): Each item on the scale is scored from 1 to 5. The overall score is used for evaluation. The lowest possible score on the Newborn Comfort Behavior Scale is 6, and the highest is 30. A total score between 9-13 indicates that the baby is comfortable, while a score between 14-30 indicates that th
about a year

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディディレクター:FERDAĞ YILDIRIM、SİVAS CUMHURİYET ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU
  • スタディディレクター:EMİNE ALTUN YILMAZ、SİVAS CUMHURİYET ÜNİVERSİTESİ SAĞLIK BİLİMLERİ FAKÜLTESİ HEMŞİRELİK BÖLÜMÜ

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年2月20日

一次修了 (実際)

2026年1月1日

研究の完了 (実際)

2026年1月1日

試験登録日

最初に提出

2026年4月1日

QC基準を満たした最初の提出物

2026年5月5日

最初の投稿 (実際)

2026年5月12日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月12日

QC基準を満たした最後の更新が送信されました

2026年5月5日

最終確認日

2025年2月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する